Omada Health
Omada Health delivers virtual-first programmes for chronic conditions such as type 2 diabetes, hypertension, and musculoskeletal pain, combining connected devices, coaching, and behavioural support. It listed on the Nasdaq in 2025.
- Founded
- 2011
- Headquarters
- San Francisco, California, US
- Founders
- Sean Duffy, Adrian James, Andrew Di Michele
- Status
- Public (Nasdaq: OMDA)
- Total funding
- ~$528M (pre-IPO)
- Latest round
- IPO (June 2025)
- Valuation
- ~$1.1B at IPO (2025)
- Category
- Digital therapeutics
- Products
- Omada virtual-first chronic-care programmes (diabetes, hypertension, MSK)
- Website
- www.omadahealth.com
Covered in: Mobile Health and Connected Devices, Digital Therapeutics
Sources
Profile compiled from the public sources listed above. Funding, valuation, and employee figures are point-in-time and may be out of date.